ReEngage is a biopharmaceutical R&D company focused on developing drugs that treat longevity-related diseases. ReEngage does this by modifying epigenetic targets that are implicated in aging-related disorders, including neurodegeneration and cancer.
Company Details
- Employees
- 3
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://Www.reengagetx.com
- Keywords
- & Capital.
Reengage Therapeutics Questions
Reengage Therapeutics's website is http://Www.reengagetx.com
Reengage Therapeutics's LinkedIn profile is https://www.linkedin.com/company/reengage-therapeutics
Reengage Therapeutics has
3 employees.
View email and phone details for 3
employees at Reengage Therapeutics.
Reengage Therapeutics's industry is
Biotechnology Research
Reengage Therapeutics's top competitors are
Woodcock Washburn Llp,
Exin Biopharma Inc.,
Rappaport Family Institute For Research In The Medical Sciences,
Recombination Therapeutics,
The Martin Law Group, Llc,
Md Anderson Cancer Center,
Red Ace Bio,
Pangea Biomed,
Cummins Intellectual Property (Ip) Law Pllc,
Epivario, Inc..
Reengage Therapeutics's categories are Biotechnology Research
Reengage Therapeutics's founding year is 2024
